Targeting MYCN and MDM2 offers new hope for cancer therapy

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug | Psychedelic Invest

TEL AVIV, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the

August 7, 2024

How smart hospitals private equity performed in the pharmaceutical industry in Q2 2023

In value terms, smart hospitals-related deal activity remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal

July 27, 2023

Study reveals population-wide immune setpoint for SARS-CoV-2 antibodies

Researchers discovered that SARS-CoV-2 antibody levels in the Dominican Republic converge to a population-wide immune setpoint, regardless of individual vaccination or infection history.

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.